Bristol-Myers Squibb Company
MULTIVALENT FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS

Last updated:

Abstract:

The present invention relates to multivalent polypeptides comprising at least two fibronectin scaffold domains connected via a polypeptide linker. The invention also relates to multivalent polypeptides for use in diagnostic, research and therapeutic applications. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and to vectors comprising the polynucleotides encoding the innovative proteins.

Status:
Application
Type:

Utility

Filling date:

6 Aug 2020

Issue date:

21 Jan 2021